121 related articles for article (PubMed ID: 6429563)
1. Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase.
Porsolt RD; Pawelec C; Roux S; Jalfre M
Neuropharmacology; 1984 May; 23(5):569-73. PubMed ID: 6429563
[TBL] [Abstract][Full Text] [Related]
2. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
Colpaert FC; Niemegeers CJ; Janssen PA
Pharmacol Biochem Behav; 1980 Oct; 13(4):513-7. PubMed ID: 6107935
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
Yasar S; Schindler CW; Thorndike EB; Szelenyi I; Goldberg SR
J Pharmacol Exp Ther; 1993 Apr; 265(1):1-6. PubMed ID: 8473997
[TBL] [Abstract][Full Text] [Related]
4. Drug discrimination analysis of pseudoephedrine in rats.
Tongjaroenbuangam W; Meksuriyen D; Govitrapong P; Kotchabhakdi N; Baldwin BA
Pharmacol Biochem Behav; 1998 Feb; 59(2):505-10. PubMed ID: 9477001
[TBL] [Abstract][Full Text] [Related]
5. A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
Yasar S; Gaál J; Panlilio LV; Justinova Z; Molnár SV; Redhi GH; Schindler CW
Psychopharmacology (Berl); 2006 Jan; 183(4):413-21. PubMed ID: 16292593
[TBL] [Abstract][Full Text] [Related]
6. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
Wooters TE; Bardo MT
Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
[TBL] [Abstract][Full Text] [Related]
7. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G
J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
[TBL] [Abstract][Full Text] [Related]
8. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
Stadler JR; Caul WF; Barrett RJ
Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
[TBL] [Abstract][Full Text] [Related]
9. d-amphetamine "cue" generalizes to social defeat stress: behavioral sensitization and attenuated accumbens dopamine.
Miczek KA; Mutschler NH; van Erp AM; Blank AD; McInerney SC
Psychopharmacology (Berl); 1999 Nov; 147(2):190-9. PubMed ID: 10591887
[TBL] [Abstract][Full Text] [Related]
10. Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.
Gatch MB; Taylor CM; Flores E; Selvig M; Forster MJ
Behav Pharmacol; 2006 Mar; 17(2):151-9. PubMed ID: 16495723
[TBL] [Abstract][Full Text] [Related]
11. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.
Goudie AJ; Atkinson J; West CR
Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.
Mechanic JA; Wasielewski JA; Carl KL; Holloway FA
Pharmacol Biochem Behav; 2002 Jul; 72(4):767-77. PubMed ID: 12062565
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of substituted amphetamine derivatives.
Corrigall WA; Coen KM; Saouda FM; Robertson JM; Lodge BA
Pharmacol Biochem Behav; 1992 Dec; 43(4):1117-9. PubMed ID: 1475294
[TBL] [Abstract][Full Text] [Related]
14. Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol.
Barrett RJ; Steranka LR
Pharmacol Biochem Behav; 1983 Apr; 18(4):611-7. PubMed ID: 6867066
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
Goudie AJ; Dubicki W; Leathley M
J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
Barrett RJ; Caul WF; Stadler JR; Smith RL
Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
[TBL] [Abstract][Full Text] [Related]
17. Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement.
Barrett RJ; Caul WF; Huffman EM; Smith RL
Psychopharmacology (Berl); 1994 Jan; 113(3-4):289-96; discussion 297-303. PubMed ID: 7862836
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
Dukat M; Wesolowska A; Young R; Glennon RA
Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
[TBL] [Abstract][Full Text] [Related]
19. Role of dopamine in d-amphetamine-induced discriminative responding.
Ho BT; Huang JT
Pharmacol Biochem Behav; 1975; 3(6):1085-92. PubMed ID: 1223898
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
